Canada News
Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over, but it may only be available in limited quantities for this fall’s respiratory virus season. Dr. Christopher Labos joins CBC News to talk about the virus and the newly approved vaccine.Credit CBC News